From ETH research to the clinic

Founded 2016ETH Zürich spin-off, Schlieren.
Research originETH Zürich and University Hospital Zürich.
QualityEN ISO 13485 quality management system.
CertifiedCE marked, TÜV SÜD EU MDR certificate.

Built on a PhD about the cervix

Pregnolia was founded in 2016, building on the PhD work of Dr. Sabrina Badir. She was part of the interdisciplinary research team at ETH Zürich and the University Hospital in Zürich that studied how the stiffness of the human uterine cervix changes during pregnancy.

The goal was to detect these changes earlier and more accurately. Today the team combines scientific, technical and medical know-how, and the Pregnolia System is CE certified and sold in selected European markets.

Spin-off ETH ZürichTÜV SÜD EN ISO 13485 certification mark

Team and board

Dr. Sabrina BadirCEO, Founder, Chairwoman of the Board
Dr. Francisco DelgadoVP R&D, Founder, Member of the Board
Isabella MoserQuality Assurance and Regulatory Affairs Manager
Dr. Laura BernardiProduct Manager, Clinical and Medical Project Manager
Marlene BissigApplication Specialist, Communication
Fabienne WiggenhauserExecutive Assistant
Dr. Marc KohlerBoard of Directors
Anna Marina EschauzierBoard of Directors

News

A second, independent study

Cervical stiffness shows potential as a novel biomarker for preterm birth, published in the European Journal of Obstetrics & Gynecology and Reproductive Biology.

EIC Accelerator funding

Pregnolia secured funding from the European Innovation Council through the EIC Accelerator programme.

UK PCN study

The first UK hospitals are preparing to introduce the Pregnolia System within the Preterm Clinical Network cohort research programme.

Visit or write to us

Pregnolia AG, Wiesenstrasse 33, 8952 Schlieren, Switzerland

+41 44 500 84 35 · info@pregnolia.com

Email the team